Back Pain News and Research

Latest Back Pain News and Research

Aerobic walking program alleviates lower back pain, says Tel Aviv University researcher

Lower back pain is a common complaint, and treatment often requires many hours of physical therapy over multiple weekly clinic visits - a costly commitment.

6 Mar 2013

Primary care practices discriminating on socioeconomic status

An audit of family physician and general practitioner offices in Canada reveals that patients with lower incomes are subject to discrimination when trying to access primary care.

27 Feb 2013

Study shows people of high socioeconomic status more likely to get access to primary care

People of high socioeconomic status are more likely to be able to access primary care than those of low socioeconomic status, even within a universal health care system in which physicians are reimbursed equally for each patient, found an article published in CMAJ.

27 Feb 2013

Offices of family physicians appear to give preference to people with chronic health conditions

Some family physicians' offices discriminate against people of low socio-economic status, even when there is no economic incentive to do so under Canada's system of publicly funded universal health insurance, new research has shown.

27 Feb 2013

Adynxx initiates AYX1 Phase 2 study to prevent post-surgical pain

Adynxx, a clinical-stage pharmaceutical company developing a first-in-class platform of therapeutics to address pain at its molecular roots, announced today that the first patient was dosed in a Phase 2 study of its lead investigational drug candidate for the prevention of post-surgical pain, AYX1.

26 Feb 2013

Harmful effects of stress may be key to managing chronic pain

For chronic pain sufferers, such as people who develop back pain after a car accident, avoiding the harmful effects of stress may be key to managing their condition.

25 Feb 2013

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB announced today two new regulatory filings with the US Food and Drug Administration (FDA) and with the European Medicines Agency (EMA) to extend the marketing authorization for Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA) and for adult patients with active axial spondyloarthritis (axSpA).

20 Feb 2013

Outcomes no better with epidural steroids for patients with spinal stenosis

For patients with spinal stenosis, epidural steroid injections (ESI) may actually lead to worse outcomes-whether or not the patient later undergoes surgery, according to a study in the February 15 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

19 Feb 2013

Antibody test ‘inappropriate’ without connective tissue symptoms

The positive antinuclear antibody test is often used inappropriately in patients without indications of connective tissue disease, real-world research suggests.

18 Feb 2013

New study reveals racial disparities in chronic pain management

Opioids are frequently prescribed for pain management in noncancer patients, but recommended clinical guidelines for monitoring effectiveness and signs of drug abuse are often not implemented. Alongside well-documented racial disparities in prescribing opioid medications for pain, researchers report racial differences in the use of recommended opioid monitoring and follow-up treatment practices.

14 Feb 2013

Research roundup: 'Shared decision making' can reduce costs, improve care; Effects of mental health parity

With shared decision making, patients and their clinicians collaboratively review the risks and benefits of available treatments options while also considering the patients' preferences and values.

10 Feb 2013

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.

10 Feb 2013

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.

28 Jan 2013

Takeda receives FDA approval for Nesina, Kazano and Oseni to treat type 2 diabetes

The U.S. Food and Drug Administration today approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.

28 Jan 2013

Cost transparency does not influence the way physicians ordered imaging tests

In a study designed to see if doctors who are told the exact price of expensive medical tests like MRIs in advance would order fewer of them, Johns Hopkins researchers got their answer: No.

24 Jan 2013

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a new use of Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer (mCRC).

23 Jan 2013

Important updates on traumatic brain injury in military personnel

Researchers are making new strides in understanding the health consequences and treatment and rehabilitation needs of combat veterans and other service members affected by traumatic brain injury (TBI).

23 Jan 2013

Roundup: Ariz. Gov. proposing hospital tax for Medicaid expansion as Nev. ponders options; Vt. hospitals form ACO

Ariz. Gov. Jan Brewer, who has become something of a conservative icon for her aggressive opposition to Mr. Obama's policies, surprised many Legislature watchers at her State of the State address last week by saying she wanted to expand the state's Medicaid program to include anyone who makes up to 133 percent of the federal poverty level, or $14,856 for an individual.

23 Jan 2013

People most often visit doctors because of skin issues, joint disorders and back pain

A new Mayo Clinic Proceedings study shows that people most often visit their health care providers because of skin issues, joint disorders and back pain. Findings may help researchers focus efforts to determine better ways to prevent and treat these conditions in large groups of people.

17 Jan 2013

Primary-care clinic treatment improves patient follow up

Treating low-acuity emergency-department patients in a primary-care clinic results in better future primary care follow up, research shows.

14 Jan 2013

Back Pain News and Research

Latest Back Pain News and Research

Aerobic walking program alleviates lower back pain, says Tel Aviv University researcher

Primary care practices discriminating on socioeconomic status

Study shows people of high socioeconomic status more likely to get access to primary care

Offices of family physicians appear to give preference to people with chronic health conditions

Adynxx initiates AYX1 Phase 2 study to prevent post-surgical pain

Harmful effects of stress may be key to managing chronic pain

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

Outcomes no better with epidural steroids for patients with spinal stenosis

Antibody test ‘inappropriate’ without connective tissue symptoms

New study reveals racial disparities in chronic pain management

Research roundup: 'Shared decision making' can reduce costs, improve care; Effects of mental health parity

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Takeda receives FDA approval for Nesina, Kazano and Oseni to treat type 2 diabetes

Cost transparency does not influence the way physicians ordered imaging tests

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Important updates on traumatic brain injury in military personnel

Roundup: Ariz. Gov. proposing hospital tax for Medicaid expansion as Nev. ponders options; Vt. hospitals form ACO

People most often visit doctors because of skin issues, joint disorders and back pain

Primary-care clinic treatment improves patient follow up

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Back Pain News and Research

Latest Back Pain News and Research

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Newsletters you may be interested in